Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Equity Stake

19 Jun 2007 11:44

Quadrise Fuels International PLC19 June 2007 19th June 2007 AIM: QFI Quadrise Fuels International plc ("Quadrise" or "the Company") Quadrise Canada Corporation acquires equity stake in Clean Energy Systems Inc Quadrise Canada Corporation ("QCC"), and Paxton Corporation ("Paxton") havejointly entered into an agreement with Clean Energy Systems Inc ("CES") ofSacramento, USA. The agreement is for an aggregate equity position in CES, afterexercise of all rights and warrants of approximately 18% on a fully dilutedbasis. Quadrise Fuels International ("QFI"), the AIM listed specialistmanufacturer of MSAR(R) emulsion fuel has a 20% equity stake in QCC and an 8%equity stake in Paxton. In exchange for this position, Paxton and QCC will provide funds for developmentof the CES power generation system. The development programme will focus ondesigning and manufacturing a 12" gas generator capable of producing 65MW ofelectrical power. CES have numerous patents and filed additional patent applications that form thebasis for the first Zero Emission Power Plant (ZEPPTM) in the USA. The CESsystem envisages oxy-firing of a wide range of fuels including the Quadriseproduct, MSAR(R). Oxy-firing permits capture of the combustion product, carbondioxide (the greenhouse gas) in a concentrated form. The high concentrationcarbon dioxide produced in this manner is of a quality suitable for injectioninto hydrocarbon reservoirs to enhance oil recovery and is of considerable valueto the petroleum industry Bill Howe, Chief Executive of Quadrise Fuels International, commented: "Carbondioxide is in short supply in North America. The CES technology offers theopportunity of co-production of saleable power and by-product carbon dioxidefrom in situ oil, together with enhanced oil recovery and simultaneouselimination of greenhouse gas emissions. For QFI, the development of a powergeneration system that was tested using MSAR(R), and has so many 'value add'features is a fundamental progression for the company." Running concurrently with the generator development programme, Paxton is workingwith CES to develop a commercial scale 65MW zero emission MSAR(R) fuelled powerplant in California. For further information, please contact: Quadrise Fuels International plcBill Howe, CEOT: +44 (0)20 7550 4930 Smith & Williamson Corporate Finance LimitedAzhic Basirov / Siobhan Sergeant+44 (0)20 7131 4000 Parkgreen CommunicationsSimon Robinson / Clare Irvine+44 (0)20 7851 7480 Notes to editors: Quadrise Fuels International plc ("Quadrise") produces an emulsion fuel as a lowcost substitute for conventional heavy fuel oil ("HFO") for use in powergeneration plants and large steam raising or energy consuming industries. In manufacturing its fuels, Quadrise uses the least valuable elements of the oilbarrel, thus providing a very cost effective product whilst simultaneouslyfacilitating a means to market for the least desirable heavy crudes and refineryderived residues. The emulsion fuel product, termed MSAR(R) (Multiphase Superfine AtomisedResidue), has superior combustion characteristics to conventional HFO and coal,and has comparable or superior environmental performance in respect ofgreenhouse emissions. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Oct 20167:00 amRNSResult of Open Offer
28th Oct 201611:53 amRNSHolding(s) in Company
26th Oct 20164:46 pmRNSHolding(s) in Company & Director/PDMR Shareholding
18th Oct 20167:00 amRNSNew Corporate Website
14th Oct 20167:00 amRNSOpen Offer
12th Oct 20162:46 pmRNSResults of Placing
12th Oct 20167:01 amRNSProposed Placing and Proposed Open Offer
12th Oct 20167:00 amRNSFinal Results
30th Sep 20167:00 amRNSOperational Update
14th Sep 20167:00 amRNSExtension of Contracts with AkzoNobel
11th Aug 20165:20 pmRNSHolding(s) in Company
10th Aug 20168:43 amRNSMemorandum of Understanding
21st Jul 20167:00 amRNSDirectorate Change
12th Jul 20164:24 pmRNSDirector/PDMR Shareholding
5th Jul 20162:05 pmRNSDirector/PDMR Shareholding
5th Jul 20167:00 amRNSEnd of Year Update
28th Jun 20163:09 pmRNSHolding(s) in Company
13th Jun 20164:40 pmRNSSecond Price Monitoring Extn
13th Jun 20164:35 pmRNSPrice Monitoring Extension
10th Jun 20164:40 pmRNSSecond Price Monitoring Extn
10th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Apr 20165:11 pmRNSIssue of Options and Director's Dealing
1st Apr 20167:00 amRNSFurther re Directorate Change
24th Mar 20164:13 pmRNSIssue of Options and Directors' Dealings
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 20163:04 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSHalf Yearly Report
17th Mar 20161:11 pmRNSMarine Programme Update
3rd Mar 20164:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:13 pmRNSNotice of Interim Results
2nd Feb 20167:00 amRNSDirectorate Change
21st Dec 20152:24 pmRNSDirector/PDMR Shareholding
17th Dec 20154:40 pmRNSSecond Price Monitoring Extn
17th Dec 20154:35 pmRNSPrice Monitoring Extension
14th Dec 20152:23 pmRNSFeasibility Study Contract
27th Nov 20154:16 pmRNSResult of AGM
23rd Nov 20157:00 amRNSDirectorate Change
19th Nov 20157:00 amRNSUpdate re Research & Development Programmes
4th Nov 20154:47 pmRNSPosting of Annual Report and Notice of AGM
2nd Nov 20154:35 pmRNSPrice Monitoring Extension
15th Oct 20154:40 pmRNSSecond Price Monitoring Extn
15th Oct 20154:35 pmRNSPrice Monitoring Extension
12th Oct 20157:00 amRNSFinal Results
1st Oct 20155:38 pmRNSHolding(s) in Company
16th Sep 20157:00 amRNSHalf Year Update on Major Active Programmes
25th Aug 20154:41 pmRNSSecond Price Monitoring Extn
25th Aug 20154:35 pmRNSPrice Monitoring Extension
13th Aug 20154:35 pmRNSPrice Monitoring Extension
12th Aug 20154:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.